Metal stents: a new treatment of malignant ureteral obstruction

J Urol. 1997 Jul;158(1):54-8. doi: 10.1097/00005392-199707000-00015.

Abstract

Purpose: We report our experience with the use of metallic self-expandable and balloon expandable stents for the treatment of malignant ureteral obstruction.

Materials and methods: We treated 12 consecutive patients with malignant ureteral obstruction, for a total of 14 ureters with stents placed. We placed metallic balloon expandable stents in 6 patients and self-expandable metallic stents in the remaining 6. Mean patient age was 65 years and mean followup was 9 months (range 8 to 16).

Results: Of the ureters 11 were patent without any additional manipulations during followup of 8 to 16 months. Secondary interventions were needed in 3 cases because of obstructive urothelial hyperplastic reaction, tumor ingrowth and local recurrence of the primary cancer invading the upper end of the stent. Two patients died 2 and 10 months after placement of the stent.

Conclusions: Both types of metal stents have advantages and disadvantages that must be balanced against each other when choosing the ideal device for the treatment of obstruction. Implantation of a metal self-expanding or balloon expanding stent is safe and effective for the palliative treatment of malignant ureteral obstruction in late stage cancer patients.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Stents* / adverse effects
  • Ureteral Neoplasms / complications*
  • Ureteral Obstruction / etiology
  • Ureteral Obstruction / surgery*